Cleared Traditional

K113375 - ESWALLOW USA ELECTRODE,ESWALLOW USA LEADWIRE

K113375 is an FDA 510(k) clearance for ESWALLOW USA ELECTRODE, manufactured by Eswallow USA. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 436-day FDA review.

K113375 · Eswallow USA · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
436d
Days
Class 2
Risk

K113375 is an FDA 510(k) clearance for the ESWALLOW USA ELECTRODE,ESWALLOW USA LEADWIRE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Eswallow USA (Guntersville, US). The FDA issued a Cleared decision on January 25, 2013 after a review of 436 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Eswallow USA devices

FDA 510(k) Submission Details - K113375

510(k) Number K113375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2011
Decision Date January 25, 2013
Days to Decision 436 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
288d slower than avg
Panel avg: 148d · This submission: 436d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 228
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K113375.
SKINTACT
K140340 · Leonhard Lang GmbH · May 2014
DYNATRON PELTIER THERMOSTIM PROBE
K132057 · Dynatronics Corp. · Jan 2014
MR CONDITIONAL CUP ELECTRODE, MR CONDITIONAL WEBB ELECTRODE
K130287 · Rhythmlink International, LLC · May 2013
PMT TRUSCAN SURFACE ELECTRODE
K122376 · Pmt Corp. · Dec 2012
SENSUS ELECTRODE
K121816 · Neurometrix, Inc. · Nov 2012
LONG LIFE PADTM
K120516 · Omron Healthcare, Inc. · May 2012